Announcements & News — iDNA Genomics Public

Financial Statements 2022 and calling of AGM 2023

Approval of financial statements 2022 and date set for AGM 2023

Investor AnnouncementsAndreas ConstantinouApril 28, 2023Financial Statements

Issue of Corporate Bonds

Issue of Corporate Bonds

Investor AnnouncementsAndreas ConstantinouMarch 1, 2023General Meeting, EGM

Issue of Additional Shares

Issue of 160.333 additional Shares following results of EGM 29.12.22

Investor AnnouncementsAndreas ConstantinouDecember 30, 2022General Meeting, EGM

Results of EGM 29.12.22

Results of the Extraordinary General Meeting of the Company

Investor AnnouncementsAndreas ConstantinouDecember 29, 2022General Meeting, EGM

BP Update - Year 2022

Updating the investing public regarding the 2022 Business Plan.

Investor AnnouncementsAndreas ConstantinouDecember 19, 2022

Calling of EGM 29.12.22

Calling of the Extraordinary General Meeting of the Company

Investor AnnouncementsAndreas ConstantinouDecember 14, 2022General Meeting, AGM

IDNA Genomics at ISPOR Europe 2022

Proud to announce our participation at ISPOR Europe 2022

Investor AnnouncementsAndreas ConstantinouNovember 18, 2022Updates, Media

Interim Financial Statements 30.06.22

The Interim Financial Statements have been approved

Investor AnnouncementsAndreas ConstantinouSeptember 26, 2022Financial Statements

Application to ΕΟΠΠΥ

Successful application for coverage of PGx-CNS product

Investor AnnouncementsAndreas ConstantinouJune 6, 2022Updates

Results of AGM 30.5.22

The results of the Annual General Meeting of the Company are available

Investor AnnouncementsAndreas ConstantinouMay 30, 2022General Meeting, AGM

Calling of AGM 30.5.22

Calling of the Annual General Meeting of the Company

Investor AnnouncementsAndreas ConstantinouMay 6, 2022General Meeting, AGM

Annual Financial Statements 31.12.21

The annual financial statements have been approved

Investor AnnouncementsAndreas ConstantinouApril 29, 2022Financial Statements